These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

997 related articles for article (PubMed ID: 29958117)

  • 1. Determinants of plasma concentrations of perfluoroalkyl and polyfluoroalkyl substances in pregnant women from a birth cohort in Shanghai, China.
    Tian Y; Zhou Y; Miao M; Wang Z; Yuan W; Liu X; Wang X; Wang Z; Wen S; Liang H
    Environ Int; 2018 Oct; 119():165-173. PubMed ID: 29958117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women.
    Ren Y; Jin L; Yang F; Liang H; Zhang Z; Du J; Song X; Miao M; Yuan W
    Environ Health; 2020 Aug; 19(1):88. PubMed ID: 32807188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal plasma concentrations of perfluoroalkyl and polyfluoroalkyl substances during pregnancy and anogenital distance in male infants.
    Tian Y; Liang H; Miao M; Yang F; Ji H; Cao W; Liu X; Zhang X; Chen A; Xiao H; Hu H; Yuan W
    Hum Reprod; 2019 Jul; 34(7):1356-1368. PubMed ID: 31242507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal plasma concentrations of Perfluoroalkyl and polyfluoroalkyl substances and neuropsychological development in children at four years of age.
    Niu J; Liang H; Tian Y; Yuan W; Xiao H; Hu H; Sun X; Song X; Wen S; Yang L; Ren Y; Miao M
    Environ Health; 2019 Jun; 18(1):53. PubMed ID: 31196101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability of perfluoroalkyl substance concentrations in pregnant women by socio-demographic and dietary factors in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Martinez D; Ibarluzea J; Santa-Marina L; Schettgen T; Vioque J; Sunyer J; Vrijheid M
    Environ Int; 2016; 92-93():357-65. PubMed ID: 27132161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants and Temporal Trends of Perfluoroalkyl Substances in Pregnant Women: The Hokkaido Study on Environment and Children's Health.
    Tsai MS; Miyashita C; Araki A; Itoh S; Bamai YA; Goudarzi H; Okada E; Kashino I; Matsuura H; Kishi R
    Int J Environ Res Public Health; 2018 May; 15(5):. PubMed ID: 29758015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal serum concentrations of per- and polyfluoroalkyl substances and their predictors in years with reduced production and use.
    Berg V; Nøst TH; Huber S; Rylander C; Hansen S; Veyhe AS; Fuskevåg OM; Odland JØ; Sandanger TM
    Environ Int; 2014 Aug; 69():58-66. PubMed ID: 24815340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of seven perfluoroalkyl and polyfluoroalkyl substances in serum of pregnant women and evaluation of neonatal neurobehavior based on high performance liquid chromatography-tandem mass spectrometry].
    Wang ZH; Liang FZ; Chen XR; Wu P; Wu W
    Se Pu; 2024 Feb; 42(2):194-202. PubMed ID: 38374600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menstrual cycle characteristics as determinants of plasma concentrations of perfluoroalkyl substances (PFASs) in the Norwegian Mother and Child Cohort (MoBa study).
    Singer AB; Whitworth KW; Haug LS; Sabaredzovic A; Impinen A; Papadopoulou E; Longnecker MP
    Environ Res; 2018 Oct; 166():78-85. PubMed ID: 29879567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perfluoroalkyl substances and lipid concentrations in plasma during pregnancy among women in the Norwegian Mother and Child Cohort Study.
    Starling AP; Engel SM; Whitworth KW; Richardson DB; Stuebe AM; Daniels JL; Haug LS; Eggesbø M; Becher G; Sabaredzovic A; Thomsen C; Wilson RE; Travlos GS; Hoppin JA; Baird DD; Longnecker MP
    Environ Int; 2014 Jan; 62():104-12. PubMed ID: 24189199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal trends and predictors of perfluoroalkyl substances serum levels in Swedish pregnant women in the SELMA study.
    Shu H; Lindh CH; Wikström S; Bornehag CG
    PLoS One; 2018; 13(12):e0209255. PubMed ID: 30596681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of plasma concentrations of perfluoroalkyl substances in pregnant Norwegian women.
    Brantsæter AL; Whitworth KW; Ydersbond TA; Haug LS; Haugen M; Knutsen HK; Thomsen C; Meltzer HM; Becher G; Sabaredzovic A; Hoppin JA; Eggesbø M; Longnecker MP
    Environ Int; 2013 Apr; 54():74-84. PubMed ID: 23419425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Perfluoroalkyl and Polyfluoroalkyl Substances Concentration and Menstrual Cycle Characteristics in Preconception Women.
    Zhou W; Zhang L; Tong C; Fang F; Zhao S; Tian Y; Tao Y; Zhang J;
    Environ Health Perspect; 2017 Jun; 125(6):067012. PubMed ID: 28657892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal exposure to perfluoroalkyl and polyfluoroalkyl substances and childhood atopic dermatitis: a prospective birth cohort study.
    Chen Q; Huang R; Hua L; Guo Y; Huang L; Zhao Y; Wang X; Zhang J
    Environ Health; 2018 Jan; 17(1):8. PubMed ID: 29343261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal exposure to perfluoroalkyl substances and associations with symptoms of attention-deficit/hyperactivity disorder and cognitive functions in preschool children.
    Skogheim TS; Villanger GD; Weyde KVF; Engel SM; Surén P; Øie MG; Skogan AH; Biele G; Zeiner P; Øvergaard KR; Haug LS; Sabaredzovic A; Aase H
    Int J Hyg Environ Health; 2020 Jan; 223(1):80-92. PubMed ID: 31653559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary intake, drinking water ingestion and plasma perfluoroalkyl substances concentration in reproductive aged Chinese women.
    Zhou W; Zhao S; Tong C; Chen L; Yu X; Yuan T; Aimuzi R; Luo F; Tian Y; Zhang J;
    Environ Int; 2019 Jun; 127():487-494. PubMed ID: 30981019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral contraceptive use as a determinant of plasma concentrations of perfluoroalkyl substances among women in the Norwegian Mother and Child Cohort (MoBa) study.
    Rush EL; Singer AB; Longnecker MP; Haug LS; Sabaredzovic A; Symanski E; Whitworth KW
    Environ Int; 2018 Mar; 112():156-164. PubMed ID: 29274593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentrations of perfluoroalkyl substances (PFASs) in human embryonic and fetal organs from first, second, and third trimester pregnancies.
    Mamsen LS; Björvang RD; Mucs D; Vinnars MT; Papadogiannakis N; Lindh CH; Andersen CY; Damdimopoulou P
    Environ Int; 2019 Mar; 124():482-492. PubMed ID: 30684806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfluoroalkyl and polyfluoroalkyl substances in cord blood of newborns in Shanghai, China: Implications for risk assessment.
    Wang B; Chen Q; Shen L; Zhao S; Pang W; Zhang J
    Environ Int; 2016 Dec; 97():7-14. PubMed ID: 27770709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perfluoroalkyl acids in pregnant women from Nunavik (Quebec, Canada): Trends in exposure and associations with country foods consumption.
    Caron-Beaudoin É; Ayotte P; Blanchette C; Muckle G; Avard E; Ricard S; Lemire M
    Environ Int; 2020 Dec; 145():106169. PubMed ID: 33041046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.